CoLucid Pharmaceuticals

CoLucid Pharmaceuticals

Developing oral lasmiditan for the treatment of migraine headache and intravenous lasmiditan for treatment of headache pain by health care professionals.

HQ location
Cambridge, United States
Website
colucid.com
Launch date
Employees
2-10 people
Enterprise value
$960m
https://twitter.com/lillypadhttps://www.facebook.com/elilillyandcohttps://www.linkedin.com/company/colucid-pharmaceuticals-inc/
    • Edit
loading funding rounds…
Novo Ventures
Novo Ventures(exited)
Domain Associates
Domain Associates(exited)
Triathlon Medical Venture Partners
Triathlon Medical Venture Partners(exited)
Pearl Street Venture Funds
Pearl Street Venture Funds(exited)
Pappas Capital
Pappas Capital(exited)
Auriga Partners
Auriga Partners(exited)
TVM Capital Healthcare Partners GmbH
TVM Capital Healthcare Partners GmbH(exited)
TVM Capital Life Science
TVM Capital Life Science(exited)
Care Capital
Care Capital(exited)
Eli Lilly
Eli Lilly

Related Content

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo